NASDAQ Composite opens in less than two hours and Gilead Sciences’s pre-market value is already 2.08% up.
The last session, NASDAQ Composite ended with Gilead Sciences jumping 1.49% to $63.33. NASDAQ Composite slid 0.87% to $12,998.50, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session.
Gilead Sciences’s last close was $63.04, 35.75% under its 52-week high of $85.97.
Gilead Sciences’s Sales
Gilead Sciences’s sales growth is 10% for the ongoing quarter and 10.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 32.3% and 4.8%, respectively.
Gilead Sciences’s last day, last week, and last month’s average volatility was 0.83%, 1.60%, and 0.15%, respectively.
Gilead Sciences’s last day, last week, and last month’s high and low average amplitude percentage was 1.44%, 2.69%, and 1.79%, respectively.